Authors: Everse, LA Anderson, LD van Rooijen, N Mullen, CA

Citation: La. Everse et al., Bone marrow transplant conditioning intensified with liposomal clodronate to eliminate residual host antigen presenting cells fails to ameliorate GVHD and increases peri-BMT mortality, TRANSPLANT, 71(5), 2001, pp. 611-618

Authors: Bernsen, MR Tang, JW Everse, LA Koten, JW Den Otter, W

Citation: Mr. Bernsen et al., Interleukin 2 (IL-2) therapy: potential advantages of locoregional versus systemic administration, CANC TR REV, 25(2), 1999, pp. 73-82

Authors: Den Otter, W Balemans, L Battermann, JJ Bernsen, MR Cadee, JA Dobrowolski, Z Everse, LA Fiszer-Maliszewska, L Gavhumende, R De Groot, JW De Groot, K Hennink, WE Hill, FWG Jurgenliemp-Schulz, I Klein, WR Koten, JW Maas, RA Steerenberg, P Stewart, R Zembala, M

Citation: W. Den Otter et al., Local low-dose IL-2 therapy, HEP-GASTRO, 46, 1999, pp. 1280-1286

Authors: Anderson, LD Petropoulos, D Everse, LA Mullen, CA

Citation: Ld. Anderson et al., Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine, CANCER RES, 59(7), 1999, pp. 1525-1530